VINC - Vincerx Pharma - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

VINC is currently covered by 4 analysts with an average price target of $10. This is a potential upside of $9.07 (975.27%) from yesterday's end of day stock price of $0.93.

Vincerx Pharma's activity chart (see below) currently has 5 price targets and 18 ratings on display. The stock rating distribution of VINC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.95% with an average time for these price targets to be met of 347.14 days.

Highest price target for VINC is $6, Lowest price target is $1, average price target is $10.

Most recent stock forecast was given by LI WATSEK from CANTOR FITZGERALD on 01-Apr-2024. First documented stock forecast 13-Aug-2021.

Currently out of the existing stock ratings of VINC, 10 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

3

$-1.78 (-37.24%)

4

1 years 5 months 9 days ago

2/3 (66.67%)

$2.2 (275.00%)

546

Buy

5

$0.22 (4.60%)

6

1 years 8 months 13 days ago

2/3 (66.67%)

$3.42 (216.46%)

604

Buy

6

$1.22 (25.52%)

12

1 years 10 months 18 days ago

1/3 (33.33%)

$4.03 (204.57%)

638

Buy

30

2 years 21 days ago

0/2 (0%)

$13.71 (84.35%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VINC (Vincerx Pharma) average time for price targets to be met?

On average it took 347.14 days on average for the stock forecasts to be realized with a an average price target met ratio 30.95

Which analyst has the current highest performing score on VINC (Vincerx Pharma) with a proven track record?

JONATHAN CHANG

Which analyst has the current lower performing score on VINC (Vincerx Pharma) with a proven track record?

MICHAEL KING

Which analyst has the most public recommendations on VINC (Vincerx Pharma)?

Jonathan Chang works at LEERINK and has 16 price targets and 11 ratings on VINC

Which analyst is the currently most bullish on VINC (Vincerx Pharma)?

Geulah Livshits with highest potential upside - $29.01

Which analyst is the currently most reserved on VINC (Vincerx Pharma)?

Matthew Barcus with lowest potential downside - -$1.78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?